December 16, 2025
1 min read

Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up last year, was hit with a warning letter from the FDA.

Leave a Reply

Your email address will not be published.

Previous Story

What Americans eat is driving global nutrition research

Next Story

Dad, Grandpa Might Be Taking A Dangerous Risk While Stoned, Survey Finds

Previous Story

What Americans eat is driving global nutrition research

Next Story

Dad, Grandpa Might Be Taking A Dangerous Risk While Stoned, Survey Finds

Latest from Blog

Go toTop